<?xml version="1.0" encoding="utf-8"?>  
		   <iati-activities version="2.03" generated-datetime="2026-10-15T19:08:34">
		   <iati-activity last-updated-datetime="2026-10-15T19:08:34"
		   xml:lang="EN" default-currency="USD" hierarchy="01">
		   <iati-identifier>XI-IATI-WBTF-TF050990</iati-identifier>
		   <reporting-org ref="XI-IATI-WBTF" type="40">  
		   		   <narrative>World Bank Trust Funds</narrative>
		   </reporting-org>
		   <title>
		   <narrative>United Nations Foundation Grant for Global Program to Eradicate Poliomyelitis	   </narrative>
		   </title>
		   <description type="1">
		   <narrative>NA </narrative>
		   </description><participating-org ref="TF702007" type="60" role="1" >
       <narrative>UN Foundation </narrative>
       </participating-org><participating-org ref="XI-IATI-WBTF" type="40" role="4" >
       <narrative>World Bank Trust Funds </narrative>
       </participating-org> <activity-status code="3"></activity-status><activity-date type="1"  iso-date= "2003-04-30"></activity-date><activity-date type="2"  iso-date= "2003-04-30"></activity-date><activity-date type="3"  iso-date= "2016-06-30"></activity-date><activity-date type="4"  iso-date= "2017-08-24"></activity-date> <contact-info type="3">
       <organisation>
       <narrative></narrative>
       </organisation>
       <department>
       <narrative>HD - IFC HNP Director</narrative>
       </department>
       <person-name>
       <narrative>Ms Aliya Kashif</narrative>
       </person-name>
       <job-title>
       <narrative>Senior Health Specialist</narrative>
       </job-title>
       <telephone>1202-458-7916</telephone>
       <email>akashif@worldbank.org</email>
       <mailing-address>
       <narrative>1818 H St, NW, Washington DC - 22036</narrative>
       </mailing-address>
       </contact-info><activity-scope code="1"></activity-scope> <recipient-region code="998">   <narrative>Bilateral unspecified</narrative>
       </recipient-region> <sector code="12250" 
	    vocabulary="1" percentage="74.74">
       <narrative>+![cdata[Infectious disease control]]+</narrative>
       </sector> <sector code="31161" 
	    vocabulary="1" percentage="25.26">
       <narrative>+![cdata[Food crop production]]+</narrative>
       </sector><collaboration-type code="2"></collaboration-type>
       <default-aid-type code="B03"></default-aid-type>
       <default-tied-status code="5"></default-tied-status><budget type="1">
       <period-start iso-date="2003-04-30"></period-start> 
       <period-end iso-date="2016-06-30"> </period-end>
       <value currency="USD" value-date="2026-03-31">91830270.00 </value>
       </budget><transaction>
	  <transaction-type code="1"></transaction-type>
       <transaction-date iso-date="2020-06-30"></transaction-date>
       <value currency="USD" value-date="2026-03-31">91830270.00  </value>
		   <description>
       <narrative>Incoming Funds (Cumulative Paid-In Contribution )-as of June 30th, 2020</narrative> 
       </description> 
	    <provider-org provider-activity-id="TF702007">
       <narrative>UN Foundation</narrative>
       </provider-org>
       <receiver-org receiver-activity-id="XI-IATI-WBTF-TF050990">
       <narrative>United Nations Foundation Grant for Global Program to Eradicate Poliomyelitis</narrative>
       </receiver-org>
       <finance-type code="110"></finance-type>
       </transaction><transaction>
	  <transaction-type code="11"></transaction-type>
       <transaction-date iso-date="2020-06-30"></transaction-date>
       <value currency="USD" value-date="2026-03-31">91830270.00  </value>
		   <description>
       <narrative>Incoming Commitment(Cumulative Signed Contribution)-as of June 30th, 2020</narrative> 
       </description> 
	    <provider-org provider-activity-id="TF702007">
       <narrative>UN Foundation</narrative>
       </provider-org>
       <receiver-org receiver-activity-id="XI-IATI-WBTF-TF050990">
       <narrative>United Nations Foundation Grant for Global Program to Eradicate Poliomyelitis</narrative>
       </receiver-org>
       <finance-type code="110"></finance-type>
       </transaction><transaction>
	  <transaction-type code="2"></transaction-type>
       <transaction-date iso-date="2020-06-30"></transaction-date>
       <value currency="USD" value-date="2026-03-31">10000000.00  </value>
		   <description>
       <narrative>Outgoing Commitment ( Total Grant Allocated Amount to Project ) - as of June 30th, 2020</narrative> 
       </description> 
	    <provider-org provider-activity-id="XI-IATI-WBTF-TF050990">
       <narrative>United Nations Foundation Grant for Global Program to Eradicate Poliomyelitis</narrative>
       </provider-org>
       <receiver-org receiver-activity-id="XI-IATI-WBTF-P124264">
       <narrative>NIGERIA</narrative>
       </receiver-org>
       <finance-type code="110"></finance-type>
       </transaction><transaction>
	  <transaction-type code="2"></transaction-type>
       <transaction-date iso-date="2020-06-30"></transaction-date>
       <value currency="USD" value-date="2026-03-31">25546258.47  </value>
		   <description>
       <narrative>Outgoing Commitment ( Total Grant Allocated Amount to Project ) - as of June 30th, 2020</narrative> 
       </description> 
	    <provider-org provider-activity-id="XI-IATI-WBTF-TF050990">
       <narrative>United Nations Foundation Grant for Global Program to Eradicate Poliomyelitis</narrative>
       </provider-org>
       <receiver-org receiver-activity-id="XI-IATI-WBTF-P076423">
       <narrative>Bilateral, unspecified</narrative>
       </receiver-org>
       <finance-type code="110"></finance-type>
       </transaction><transaction>
	  <transaction-type code="2"></transaction-type>
       <transaction-date iso-date="2020-06-30"></transaction-date>
       <value currency="USD" value-date="2026-03-31">46143761.57  </value>
		   <description>
       <narrative>Outgoing Commitment ( Total Grant Allocated Amount to Project ) - as of June 30th, 2020</narrative> 
       </description> 
	    <provider-org provider-activity-id="XI-IATI-WBTF-TF050990">
       <narrative>United Nations Foundation Grant for Global Program to Eradicate Poliomyelitis</narrative>
       </provider-org>
       <receiver-org receiver-activity-id="XI-IATI-WBTF-P080295">
       <narrative>NIGERIA</narrative>
       </receiver-org>
       <finance-type code="110"></finance-type>
       </transaction><transaction>
	  <transaction-type code="2"></transaction-type>
       <transaction-date iso-date="2020-06-30"></transaction-date>
       <value currency="USD" value-date="2026-03-31">9458623.77  </value>
		   <description>
       <narrative>Outgoing Commitment ( Total Grant Allocated Amount to Project ) - as of June 30th, 2020</narrative> 
       </description> 
	    <provider-org provider-activity-id="XI-IATI-WBTF-TF050990">
       <narrative>United Nations Foundation Grant for Global Program to Eradicate Poliomyelitis</narrative>
       </provider-org>
       <receiver-org receiver-activity-id="XI-IATI-WBTF-P114508">
       <narrative>PAKISTAN</narrative>
       </receiver-org>
       <finance-type code="110"></finance-type>
       </transaction><transaction>
	  <transaction-type code="2"></transaction-type>
       <transaction-date iso-date="2020-06-30"></transaction-date>
       <value currency="USD" value-date="2026-03-31">9983448.90  </value>
		   <description>
       <narrative>Outgoing Commitment ( Total Grant Allocated Amount to Project ) - as of June 30th, 2020</narrative> 
       </description> 
	    <provider-org provider-activity-id="XI-IATI-WBTF-TF050990">
       <narrative>United Nations Foundation Grant for Global Program to Eradicate Poliomyelitis</narrative>
       </provider-org>
       <receiver-org receiver-activity-id="XI-IATI-WBTF-P130865">
       <narrative>NIGERIA</narrative>
       </receiver-org>
       <finance-type code="110"></finance-type>
       </transaction><related-activity ref="XI-IATI-WBTF-P076423"  type="2"></related-activity><related-activity ref="XI-IATI-WBTF-P080295"  type="4"></related-activity><related-activity ref="XI-IATI-WBTF-P114508"  type="4"></related-activity><related-activity ref="XI-IATI-WBTF-P124264"  type="4"></related-activity><related-activity ref="XI-IATI-WBTF-P130865"  type="4"></related-activity>
   </iati-activity>	<iati-activity last-updated-datetime="2026-10-15T19:08:36"
	   xml:lang="EN" default-currency="USD" hierarchy="02">
       <iati-identifier>XI-IATI-WBTF-P080295</iati-identifier>
       <reporting-org ref="XI-IATI-WBTF"  type="40">
       <narrative>World Bank Trust Funds</narrative>
       </reporting-org>
       <title>
       <narrative>Partnership for Polio Eradication Project</narrative>
       </title>
       <description type="1">
       <narrative>The development objective of the Project is to assist, as part of a global polio eradication effort, the Government of Nigeria to achieve its goal of interrupting the transmission of wild polio virus, and to sustain these efforts throughout the implementation of the Project, through effective OPV coverage of the target population.  </narrative>
	   </description><participating-org ref="DAC-1601" type="60" role="1" >
       <narrative>Bill and Melinda Gates Foundation </narrative>
       </participating-org><participating-org ref="TF050498" type="40" role="4" >
       <narrative>Gates - World Bank Partnership for Enhanced Project and Policy Support </narrative>
       </participating-org><participating-org ref="TF050990" type="40" role="4" >
       <narrative>United Nations Foundation Grant for Global Program to Eradicate Poliomyelitis </narrative>
       </participating-org><participating-org ref="TF702007" type="60" role="1" >
       <narrative>UN Foundation </narrative>
       </participating-org> <activity-status code="3"></activity-status><activity-date type="1"  iso-date= "2002-08-05"></activity-date><activity-date type="2"  iso-date= "2002-08-05"></activity-date><activity-date type="3"  iso-date= "2015-09-30"></activity-date><activity-date type="4"  iso-date= "2013-08-13"></activity-date> <contact-info type="2">
       <organisation>
       <narrative></narrative>
       </organisation>
       <department>
       <narrative></narrative>
       </department>
       <person-name>
       <narrative>Mr Dinesh M. Nair</narrative>
       </person-name>
       <job-title>
       <narrative>Senior Health Specialist</narrative>
       </job-title>
       <telephone>1202-458-7916</telephone>
       <email>dnair@worldbank.org</email>
       <mailing-address>
       <narrative>1818 H St, NW, Washington DC - 22036</narrative>
       </mailing-address>
       </contact-info><activity-scope code="4"></activity-scope>  <recipient-country code="NG">     <narrative>NIGERIA</narrative>
       </recipient-country> <sector code="12250"  vocabulary="1" percentage="100.00">
       <narrative>+![cdata[Infectious disease control]]+</narrative>
       </sector><collaboration-type code="2"></collaboration-type>
       <default-aid-type code="C01"></default-aid-type>
       <default-tied-status code="5"></default-tied-status><budget type="1">
       <period-start iso-date="2002-08-05"></period-start> 
       <period-end iso-date="2015-09-30"> </period-end>
       <value currency="USD" value-date="2026-03-31">46328691.34 </value>
       </budget><transaction>
	  <transaction-type code="11"></transaction-type>
       <transaction-date iso-date="2020-06-30"></transaction-date>
       <value currency="USD" value-date="2026-03-31">184929.77  </value>
		   <description>
       <narrative>Allocation to Bank executed activities - as of June 30th, 2020</narrative> 
       </description> 
	    <provider-org provider-activity-id="XI-IATI-WBTF-TF050498">
       <narrative>Gates - World Bank Partnership for Enhanced Project and Policy Support</narrative>
       </provider-org>
       <receiver-org receiver-activity-id="P080295">
       <narrative>NIGERIA</narrative>
       </receiver-org>
       <finance-type code="110"></finance-type>
       </transaction><transaction>
	  <transaction-type code="11"></transaction-type>
       <transaction-date iso-date="2020-06-30"></transaction-date>
       <value currency="USD" value-date="2026-03-31">46143761.57  </value>
		   <description>
       <narrative>Incoming Commitment (Total Grant Allocated Amount) - as of June 30th, 2020</narrative> 
       </description> 
	    <provider-org provider-activity-id="XI-IATI-WBTF-TF050990">
       <narrative>United Nations Foundation Grant for Global Program to Eradicate Poliomyelitis</narrative>
       </provider-org>
       <receiver-org receiver-activity-id="P080295">
       <narrative>NIGERIA</narrative>
       </receiver-org>
       <finance-type code="110"></finance-type>
       </transaction><transaction>
	  <transaction-type code="3"></transaction-type>
       <transaction-date iso-date="2020-06-30"></transaction-date>
       <value currency="USD" value-date="2026-03-31">46143761.57  </value>
		   <description>
       <narrative>Disbursement(Total Recipient-Executed Trust Funds Disbursements ) - as of June 30th, 2020</narrative> 
       </description>
	    <provider-org provider-activity-id="XI-IATI-WBTF">
       <narrative>World Bank Trust Funds</narrative>
       </provider-org>
       <receiver-org receiver-activity-id="XI-IATI-WBTF-P080295">
       <narrative>NIGERIA</narrative>
       </receiver-org>
       <finance-type code="110"></finance-type>
       </transaction><transaction>
	  <transaction-type code="4"></transaction-type>
       <transaction-date iso-date="2020-06-30"></transaction-date>
       <value currency="USD" value-date="2026-03-31">184929.77  </value>
		   <description>
       <narrative>Cumulative Expenditures to Bank executed activities - as of June 30th, 2020</narrative> 
       </description>
	    <provider-org provider-activity-id="XI-IATI-WBTF">
       <narrative>World Bank Trust Funds</narrative>
       </provider-org>
       <receiver-org receiver-activity-id="XI-IATI-WBTF-P080295">
       <narrative>NIGERIA</narrative>
       </receiver-org>
       <finance-type code="110"></finance-type>
       </transaction><related-activity ref="44000-P080295" type="4"></related-activity><related-activity ref="XI-IATI-WBTF-TF050498" type="1"></related-activity><related-activity ref="XI-IATI-WBTF-TF050990" type="1"></related-activity><result type="2" aggregation-status="1">
<title><narrative>
 PDO Indicator 
</narrative></title>

								<indicator measure="1" ascending="1">

															<title><narrative>
Children immunized (number)
</narrative></title> 
<baseline year="2010" iso-date="2010-12-31" value="281000000.00"><comment>
					<narrative>number of children immunized in the  year 2010 (UNICEF/ WHO SIA data). This new indicator included as part of 3rd additionalfinancing. The target age group is approximately 40million children. With six cohorts of children each child in in high risk statesmay get in campaigns  9 OPV doses  each year. In the middle risk states, child would receive up to 4  OPV doses each year while inthe low risk states, children would receive 2 OPV doses a year. As the program does not disaggregate by gender estimated femalebeneficiaries would be  140500000.</narrative></comment></baseline>

																	<period>
																	<period-start iso-date="2010-12-31" /> <period-end iso-date="1900-01-01"/>
<target value="0.00">


																	</target>

																	<actual value="113500000.00">

																	<comment><narrative>

																		number of children immunized to date  in year 2012 (UNICEF/ WHO SIA data). Cumulative between 2010 to April 2012 is 750.7million Asthe program does not disaggregate by gender estimated female beneficiaries would be  56750000.
</narrative></comment>

																	</actual>

																	</period>
</indicator>
</result><result type="2" aggregation-status="0">
<title><narrative>
 PDO Indicator 
</narrative></title>

								<indicator measure="1" ascending="1">

															<title><narrative>
Monthly onset of Wild Polio Virus Type 1
</narrative></title> 
<baseline year="2003" iso-date="2003-04-04" value="155.00"><comment>
					<narrative></narrative></comment></baseline>

																	<period>
																	<period-start iso-date="2003-04-04" /> <period-end iso-date="1900-01-01"/>
<target value="0.00">


																	</target>

																	<actual value="11.00">

																	<comment><narrative>

																		Annual cumulative figure to dateUNICEF/ WHO SIA data
</narrative></comment>

																	</actual>

																	</period>
</indicator>
</result><result type="2" aggregation-status="0">
<title><narrative>
 PDO Indicator 
</narrative></title>

								<indicator measure="1" ascending="1">

															<title><narrative>
Monthly onset of Wild Polio Virus Type 3
</narrative></title> 
<baseline year="2003" iso-date="2003-04-04" value="26.00"><comment>
					<narrative></narrative></comment></baseline>

																	<period>
																	<period-start iso-date="2003-04-04" /> <period-end iso-date="1900-01-01"/>
<target value="0.00">


																	</target>

																	<actual value="4.00">

																	<comment><narrative>

																		Annual cumulative figure to dateUNICEF/ WHO SIA data
</narrative></comment>

																	</actual>

																	</period>
</indicator>
</result><result type="1" aggregation-status="0">
<title><narrative>
 Intermediate Results Indicator 
</narrative></title>

								<indicator measure="1" ascending="1">

															<title><narrative>
Doses of OPV distributed
</narrative></title> 
<baseline year="1900" value="000000"><comment>
					<narrative></narrative></comment></baseline>

																	<period>
																	<period-start iso-date="2003-04-29" /> <period-end iso-date="1900-01-01"/>
<target value="0.00">


																	</target>

																	<actual value="128869520.00">

																	<comment><narrative>

																		Annual Cumulative Year to Date (UNICEF/ WHO SIA data)
</narrative></comment>

																	</actual>

																	</period>
</indicator>
</result><result type="1" aggregation-status="0">
<title><narrative>
 Intermediate Results Indicator 
</narrative></title>

								<indicator measure="1" ascending="1">

															<title><narrative>
Immunization rounds conducted
</narrative></title> 
<baseline year="1900" value="000000"><comment>
					<narrative></narrative></comment></baseline>

																	<period>
																	<period-start iso-date="2003-04-29" /> <period-end iso-date="1900-01-01"/>
<target value="0.00">


																	</target>

																	<actual value="2.00">

																	<comment><narrative>

																		2 National rounds conducted
</narrative></comment>

																	</actual>

																	</period>
</indicator>
</result><result type="1" aggregation-status="0">
<title><narrative>
 Intermediate Results Indicator 
</narrative></title>

								<indicator measure="5" ascending="1">

															<title><narrative>
Timely delivery of OPV for use in FGN polio eradication program
</narrative></title> 
<baseline year="2003" iso-date="2003-08-06" value="Erratic vacccine arrival"><comment>
					<narrative></narrative></comment></baseline>

																	<period>
																	<period-start iso-date="2003-08-06" />  <period-end iso-date="2012-04-29" />
<target value="timely arrival">


																	</target>

																	<actual value="Timely arrival">

																	<comment><narrative>

																		Vaccines delivered timely confirmed at performance audit in 2011. There has been no interruption of the campaign because ofvaccineavailability.
</narrative></comment>

																	</actual>

																	</period>
</indicator>
</result><result type="1" aggregation-status="0">
<title><narrative>
 Intermediate Results Indicator 
</narrative></title>

								<indicator measure="5" ascending="1">

															<title><narrative>
Cold chain system established and operational
</narrative></title> 
<baseline year="2003" iso-date="2003-08-06" value="Not effective"><comment>
					<narrative></narrative></comment></baseline>

																	<period>
																	<period-start iso-date="2003-08-06" />  <period-end iso-date="2012-04-29" />
<target value="Effective">


																	</target>

																	<actual value="operational and effective">

																	<comment><narrative>

																		Phased roll out of cold chain strengthening being carried out in conformity with new vaccine introductions
</narrative></comment>

																	</actual>

																	</period>
</indicator>
</result><result type="1" aggregation-status="0">
<title><narrative>
 Intermediate Results Indicator 
</narrative></title>

								<indicator measure="5" ascending="1">

															<title><narrative>
Social Mobilization Program implemented
</narrative></title> 
<baseline year="2003" iso-date="2003-08-06" value="Not implemented"><comment>
					<narrative></narrative></comment></baseline>

																	<period>
																	<period-start iso-date="2003-08-06" />  <period-end iso-date="2012-04-29" />
<target value="Fully implemented">


																	</target>

																	<actual value="implemented">

																	<comment><narrative>

																		With the engagement of traditional and religious leaders in the program there is a clear increase in acceptance of the polioimmunization. Special efforts have been mobilized to address migratory populations .
</narrative></comment>

																	</actual>

																	</period>
</indicator>
</result><result type="1" aggregation-status="0">
<title><narrative>
 Intermediate Results Indicator 
</narrative></title>

								<indicator measure="5" ascending="1">

															<title><narrative>
Targeted capacity building program implemented
</narrative></title> 
<baseline year="2003" iso-date="2003-08-06" value="Not started"><comment>
					<narrative></narrative></comment></baseline>

																	<period>
																	<period-start iso-date="2003-08-06" />  <period-end iso-date="2012-04-29" />
<target value="Program implemented">


																	</target>

																	<actual value="Implemented">

																	<comment><narrative>

																		Prior to each campaign (whether nationwide or sub-national), the State and LGA teams, State Technical Facilitators, Ward FocalPersons, team supervisors and team members are trained. The trainings are done in a cascading manner.
</narrative></comment>

																	</actual>

																	</period>
</indicator>
</result><result type="1" aggregation-status="0">
<title><narrative>
 Intermediate Results Indicator 
</narrative></title>

								<indicator measure="5" ascending="1">

															<title><narrative>
Bank participation in the ICC, assessing outputs and DO
</narrative></title> 
<baseline year="2003" iso-date="2003-08-06" value="N.A."><comment>
					<narrative></narrative></comment></baseline>

																	<period>
																	<period-start iso-date="2003-08-06" />  <period-end iso-date="2012-04-29" />
<target value="Full Bank participation">


																	</target>

																	<actual value="Full participation- Bank TTL present in all ICC me">

																	<comment><narrative>

																		meeting minutes
</narrative></comment>

																	</actual>

																	</period>
</indicator>
</result><result type="1" aggregation-status="0">
<title><narrative>
 Intermediate Results Indicator 
</narrative></title>

								<indicator measure="5" ascending="1">

															<title><narrative>
Surveillance program (cases per 100k, stool sample collection).
</narrative></title> 
<baseline year="2003" iso-date="2003-08-06" value="N.A."><comment>
					<narrative></narrative></comment></baseline>

																	<period>
																	<period-start iso-date="2003-08-06" />  <period-end iso-date="2012-04-29" />
<target value="effective">


																	</target>

																	<actual value="781">

																	<comment><narrative>

																		WHO AFP surveillance is a well established/good quality system. Surveillance is undertaken -continuously and weekly reports of thesort attached to this ISR are produced by WHO. Standard parameters of achievement maintained. UNICEF/ WHO SIA data
</narrative></comment>

																	</actual>

																	</period>
</indicator>
</result><result type="1" aggregation-status="0">
<title><narrative>
 Intermediate Results Indicator 
</narrative></title>

								<indicator measure="5" ascending="1">

															<title><narrative>
WHO audit:  inputs, outputs, DO triggers for buy-down;
</narrative></title> 
<baseline year="2003" iso-date="2003-08-06" value="N.A."><comment>
					<narrative></narrative></comment></baseline>

																	<period>
																	<period-start iso-date="2003-08-06" />  <period-end iso-date="2012-04-29" />
<target value="Audits received by IDA">


																	</target>

																	<actual value="final performance audit to be carried out in Augus">

																	<comment><narrative>

																		Commissioned reports
</narrative></comment>

																	</actual>

																	</period>
</indicator>
</result><result type="2" aggregation-status="0">
<title><narrative>
 PDO Indicator 
</narrative></title>

								<indicator measure="5" ascending="1">

															<title><narrative>
Effective OPV coverage of the target population
</narrative></title> 
<baseline year="2003" iso-date="2003-08-06" value="20-30%"><comment>
					<narrative>based on NPI data compiled at start of project</narrative></comment></baseline>

																	<period>
																	<period-start iso-date="2003-08-06" />  <period-end iso-date="2012-04-29" />
<target value="at least 80% in each endemic state">


																	</target>

																	<actual value="91.8">

																	<comment><narrative>

																		UNICEF/WHO SIA data, March 2012 , confirmed by the State level breakdowns of the NPHCDA (reported coverage)
</narrative></comment>

																	</actual>

																	</period>
</indicator>
</result></iati-activity><iati-activity last-updated-datetime="2026-10-15T19:08:38"
	   xml:lang="EN" default-currency="USD" hierarchy="02">
       <iati-identifier>XI-IATI-WBTF-P124264</iati-identifier>
       <reporting-org ref="XI-IATI-WBTF"  type="40">
       <narrative>World Bank Trust Funds</narrative>
       </reporting-org>
       <title>
       <narrative>Partnership for Polio Eradication Project - 3rd Additional Financing (FY11)</narrative>
       </title>
       <description type="1">
       <narrative>The development objective of the Project is to assist, as part of a global polio eradication effort, the Government of Nigeria to achieve its goal of interrupting the transmission of wild polio virus, and to sustain these efforts throughout the implementation of the Project, through effective OPV coverage of the target population.  </narrative>
	   </description><participating-org ref="DAC-1601" type="60" role="1" >
       <narrative>Bill and Melinda Gates Foundation </narrative>
       </participating-org><participating-org ref="TF050775" type="40" role="4" >
       <narrative>Gates Foundation Grant for Global Program to Eradicate Poliomyelitis </narrative>
       </participating-org><participating-org ref="TF050990" type="40" role="4" >
       <narrative>United Nations Foundation Grant for Global Program to Eradicate Poliomyelitis </narrative>
       </participating-org><participating-org ref="TF702007" type="60" role="1" >
       <narrative>UN Foundation </narrative>
       </participating-org> <activity-status code="3"></activity-status><activity-date type="1"  iso-date= "2011-05-13"></activity-date><activity-date type="2"  iso-date= "2011-05-13"></activity-date><activity-date type="3"  iso-date= "2013-10-31"></activity-date><activity-date type="4"  iso-date= "2013-11-19"></activity-date> <contact-info type="2">
       <organisation>
       <narrative></narrative>
       </organisation>
       <department>
       <narrative></narrative>
       </department>
       <person-name>
       <narrative>Mr Shunsuke Mabuchi</narrative>
       </person-name>
       <job-title>
       <narrative>Senior Health Specialist</narrative>
       </job-title>
       <telephone>1202-458-7916</telephone>
       <email></email>
       <mailing-address>
       <narrative>1818 H St, NW, Washington DC - 22036</narrative>
       </mailing-address>
       </contact-info><activity-scope code="4"></activity-scope>  <recipient-country code="NG">     <narrative>NIGERIA</narrative>
       </recipient-country> <sector code="12250"  vocabulary="1" percentage="100.00">
       <narrative>+![cdata[Infectious disease control]]+</narrative>
       </sector><collaboration-type code="2"></collaboration-type>
       <default-aid-type code="C01"></default-aid-type>
       <default-tied-status code="5"></default-tied-status><budget type="1">
       <period-start iso-date="2011-05-13"></period-start> 
       <period-end iso-date="2013-10-31"> </period-end>
       <value currency="USD" value-date="2026-03-31">27491931.39 </value>
       </budget><transaction>
	  <transaction-type code="11"></transaction-type>
       <transaction-date iso-date="2020-06-30"></transaction-date>
       <value currency="USD" value-date="2026-03-31">10000000.00  </value>
		   <description>
       <narrative>Incoming Commitment (Total Grant Allocated Amount) - as of June 30th, 2020</narrative> 
       </description> 
	    <provider-org provider-activity-id="XI-IATI-WBTF-TF050990">
       <narrative>United Nations Foundation Grant for Global Program to Eradicate Poliomyelitis</narrative>
       </provider-org>
       <receiver-org receiver-activity-id="P124264">
       <narrative>NIGERIA</narrative>
       </receiver-org>
       <finance-type code="110"></finance-type>
       </transaction><transaction>
	  <transaction-type code="11"></transaction-type>
       <transaction-date iso-date="2020-06-30"></transaction-date>
       <value currency="USD" value-date="2026-03-31">17491931.39  </value>
		   <description>
       <narrative>Incoming Commitment (Total Grant Allocated Amount) - as of June 30th, 2020</narrative> 
       </description> 
	    <provider-org provider-activity-id="XI-IATI-WBTF-TF050775">
       <narrative>Gates Foundation Grant for Global Program to Eradicate Poliomyelitis</narrative>
       </provider-org>
       <receiver-org receiver-activity-id="P124264">
       <narrative>NIGERIA</narrative>
       </receiver-org>
       <finance-type code="110"></finance-type>
       </transaction><transaction>
	  <transaction-type code="3"></transaction-type>
       <transaction-date iso-date="2020-06-30"></transaction-date>
       <value currency="USD" value-date="2026-03-31">27491931.39  </value>
		   <description>
       <narrative>Disbursement(Total Recipient-Executed Trust Funds Disbursements ) - as of June 30th, 2020</narrative> 
       </description>
	    <provider-org provider-activity-id="XI-IATI-WBTF">
       <narrative>World Bank Trust Funds</narrative>
       </provider-org>
       <receiver-org receiver-activity-id="XI-IATI-WBTF-P124264">
       <narrative>NIGERIA</narrative>
       </receiver-org>
       <finance-type code="110"></finance-type>
       </transaction><related-activity ref="XI-IATI-WBTF-TF050990" type="1"></related-activity><related-activity ref="XI-IATI-WBTF-TF050775" type="1"></related-activity><related-activity ref="44000-P124264" type="4"></related-activity></iati-activity></iati-activities>